Effect of ertugliflozin on left ventricular function in type 2 diabetes and pre-heart failure: the Ertu-GLS randomized clinical trial

Abstract Background The therapeutic effects of ertugliflozin, a sodium-glucose cotransporter 2 inhibitor, on cardiovascular outcome are not fully understood. This study aimed to evaluate the efficacy and safety of ertugliflozin on cardiac function in people with type 2 diabetes and pre-heart failure...

Full description

Bibliographic Details

Published in:	Cardiovascular Diabetology
Main Authors:	Soo Lim, Jae Hyun Bae, Heran Oh, In-Chang Hwang, Yeonyee E. Yoon, Goo-Yeong Cho
Format:	Article
Language:	English
Published:	BMC 2024-10-01
Subjects:	Angiotensin-converting enzyme 2 Angiotensin (1–7) Diabetes mellitus, type 2 Ertugliflozin Global longitudinal strain Heart function tests
Online Access:	https://doi.org/10.1186/s12933-024-02463-0